• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB

CAMBIUM BIO LIMITED

4.21% ! 49.5¢
Market Cap $11.31M  !

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 05/09/25 2 224
05/09/25 Last post  Pierzzxx Comments Created with Sketch.  2  Views Created with Sketch.  224 
CMB 02/09/25 2 305
02/09/25 Last post  Pierzzxx Comments Created with Sketch.  2  Views Created with Sketch.  305 
CMB 29/08/25 0 60
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  60 
CMB 29/08/25 0 75
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  75 
CMB 29/08/25 0 47
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  47 
CMB 29/08/25 0 48
29/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  48 
CMB 27/08/25 0 85
27/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  85 
CMB 27/08/25 1 203
27/08/25 Last post  tony123 Comments Created with Sketch.  1  Views Created with Sketch.  203 

See All Discussions arrow Created with Sketch.

Timeline

Cambium Bio Signs Strategic MoU with Benta SAS
05 Sep 11:37
 
Cambium Bio Signs US$2.0M plus Licensing Deal
02 Sep 13:07
 
FY25 Appendix 4G and Corporate Governance Statement
29 Aug 16:00
 
FY25 Appendix 4E and Annual Report
29 Aug 15:56
 
Cleansing notice
29 Aug 09:23
 
Application for quotation of securities - CMB
29 Aug 09:21
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
49.5¢
Change
0.020(4.21%)
Mkt cap ! $11.31M
Open High Low Value Volume
47.5¢ 55.0¢ 46.5¢ $41.36K 86.73K

Buyers (Bids)

No. Vol. Price($)
1 4426 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.0¢ 402 1
View Market Depth
Last trade - 12.52pm 05/09/2025 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.